Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

ASPO 45th Annual Meeting Abstracts

Implementation of QI Coaching Versus Physician Communication Training for Improving HPV Vaccination in Primary Care: A Randomized Implementation Trial

BK Grabert, R Kurtzman, J Heisler-MacKinnon, J Leeman, A Bjork, Dailey S Alton, NT Brewer and MB Gilkey
BK Grabert
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R Kurtzman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Heisler-MacKinnon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Leeman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A Bjork
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dailey S Alton
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NT Brewer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MB Gilkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1055-9965.EPI-21-0209 Published April 2021
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Purpose of study: Health departments (HDs) are at the forefront of efforts to improve HPV vaccine uptake in the US. Most notably, HD staff routinely conduct in-person quality improvement (QI) coaching to help primary care clinics improve their vaccine delivery systems. Some HDs also engage outside experts to conduct remote physician communication training to help vaccine prescribers recommend HPV vaccine more effectively. To guide future HD programming, we sought to understand the implementation strengths and challenges of QI coaching and physician communication training. Methods: In a cluster randomized trial, we allocated 855 primary care clinics in 3 geographically-diverse US states to receive: 1) QI coaching; 2) physician communication training; or 3) both interventions combined. In each arm, we assessed adoption (or the % of clinics receiving the allocated intervention out of those invited), contacts per clinic (mean number of contacts needed to successfully schedule one clinic), reach (median number of total staff and prescriber participants per clinic), and delivery cost. Results: More clinics adopted QI coaching than communication training or the combined intervention (63% vs 16% and 12%, both p<.05). Recruiting clinics into QI coaching sessions required fewer contacts than communication training or the combined intervention (mean = 4.7 vs 29.0 and 40.4, both p<.05). In contrast, communication training and the combined intervention reached more total staff per clinic than QI coaching (median = 5 and 5 vs 2, both p<.05), including more prescribers per clinic (2 and 2 vs 0, both p<.05). QI coaching cost $439 per clinic on average, including costs incurred from follow up ($129/clinic), session preparation ($73/clinic), and travel ($69/clinic). Communication training cost $1,287 per clinic, with most cost incurred from clinic recruitment ($653/clinic). Conclusions: QI coaching was lower cost and had higher adoption, but remote communication training achieved higher reach, including to highly influential vaccine prescribers. Thus, communication training is a promising intervention for improving HPV vaccine delivery, although care will be needed to overcome substantial challenges to clinic recruitment.

The following are the 23 highest scoring abstracts of those submitted for presentation at the 45th Annual ASPO meeting held virtually March 29 – April 1, 2021.

  • ©2021 American Association for Cancer Research.
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 30 (4)
April 2021
Volume 30, Issue 4
  • Table of Contents
  • Table of Contents (PDF)
  • Editorial Board (PDF)

Sign up for alerts

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Implementation of QI Coaching Versus Physician Communication Training for Improving HPV Vaccination in Primary Care: A Randomized Implementation Trial
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Implementation of QI Coaching Versus Physician Communication Training for Improving HPV Vaccination in Primary Care: A Randomized Implementation Trial
BK Grabert, R Kurtzman, J Heisler-MacKinnon, J Leeman, A Bjork, Dailey S Alton, NT Brewer and MB Gilkey
Cancer Epidemiol Biomarkers Prev April 1 2021 (30) (4) 805; DOI: 10.1158/1055-9965.EPI-21-0209

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Implementation of QI Coaching Versus Physician Communication Training for Improving HPV Vaccination in Primary Care: A Randomized Implementation Trial
BK Grabert, R Kurtzman, J Heisler-MacKinnon, J Leeman, A Bjork, Dailey S Alton, NT Brewer and MB Gilkey
Cancer Epidemiol Biomarkers Prev April 1 2021 (30) (4) 805; DOI: 10.1158/1055-9965.EPI-21-0209
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Multilevel Risk Factors for Weight Change after Breast Cancer Diagnosis Among Black Women
  • Financial and Employment Impacts of Cancer and COVID-19 Among African American Cancer Survivors
  • Social Support and Mental Health during the COVID19-pandemic among Cancer Survivors: An Analysis of the COVID Impact Survey
Show more ASPO 45th Annual Meeting Abstracts
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement